Advertisement
Product › Details
Eiger2 R 500K Hybrid Photon Counting (HPC) pixel detector
Next higher product group | Hybrid Photon Counting (HPC) pixel detector | |
Status | 2017-08-22 sales start | |
Organisation | Dectris Ltd. (CH) | |
Bruker Corporation. (8/22/17). "Press Release: Bruker and Dectris Announce Advances in D8 X-ray Diffraction Systems with the New Eiger2 R 500K Detector". Hyderabad.
At the 24th Congress and General Assembly of the International Union of Crystallography (IUCr), Bruker and DECTRIS today announce the EIGER2 R 500K, the latest generation of Hybrid Photon Counting (HPC) pixel detectors developed by DECTRIS, the technology leader for HPC detectors for laboratory instrumentation and synchrotron beam lines. In close collaboration, DECTRIS and BRUKER have seamlessly integrated this outstanding 2D detector into Bruker's D8 ADVANCETM and D8 DISCOVERTM instrument platforms to further improve performance for numerous X-ray diffraction (XRD) applications.
The most recent generation of the proprietary EIGER HPC detector offers a distinctive set of enhanced and new benefits for XRD: high frame rate enabling 2D data collection in continuous scanning mode, single photon counting without spatial distortion, highest count rates and dynamic range. In combination with the Bruker D8TM X-ray diffraction systems, switching between 0D, 1D and 2D mode is possible.
These new features are fully integrated into the Bruker D8 X-ray diffraction systems, and enable the EIGER2 R 500K detector to produce excellent diffraction data for applications from powder diffraction (XRPD), micro diffraction (µXRD), texture or residual stress analysis, crystallite size determination, thin film analysis by X-ray reflectometry (XRR) and high-resolution diffraction (HRXRD) to small angle X-ray scattering (SAXS and GISAXS). This powerful combination of the D8 ADVANCE or the D8 DISCOVER with the EIGER2 R 500K significantly extends and speeds up the analysis capabilities for XRD users.
"Collaborating from the early stage in the product development, we were able to provide our new EIGER2 R 500K detector with seamless integration into Bruker AXS D8 XRD systems. This is enabling customers to take advantage of cutting-edge detector technology for their laboratory right from the launch", stated Christian Broennimann, the CEO of DECTRIS.
Dr. Lutz Bruegemann, the Bruker AXS Vice President and General Manager XRD, added, "The coordinated development teams at DECTRIS and Bruker have done a tremendous job. The result is outstanding synergy between the latest HPC detector technology and the most powerful and user-friendly XRD platform on the market, enabling customers to use the new EIGER2 R 500K seamlessly incorporated into our D8 diffraction solutions for many important applications."
About Bruker Corporation (NASDAQ: BRKR)
For more than 55 years, Bruker has enabled scientists to make breakthrough discoveries and develop new applications that improve the quality of human life. Bruker's high-performance scientific instruments and high-value analytical and diagnostic solutions enable scientists to explore life and materials at molecular, cellular and microscopic levels. In close cooperation with our customers, Bruker is enabling innovation, productivity and customer success in life science molecular research, in applied and pharma applications, in microscopy, nanoanalysis and industrial applications, as well as in cell biology, preclinical imaging, clinical phenomics and proteomics research, clinical microbiology and molecular pathology research. For more information, visit www.bruker.com.
About DECTRIS Ltd.
DECTRIS is the global leader in hybrid photon counting (HPC) x-ray detection. Based in Baden, Switzerland, the company has all the required experiences and resources for the design, production and global distribution of its detectors.
The DECTRIS photon counting detectors have transformed basic research at synchrotron light sources, as well as in the laboratory and with industrial X-ray applications. DECTRIS aims to continuously improve the measurement quality, thereby enabling new scientific findings. This pioneering technology is the basis of a broad range of products, all scaled to meet the needs of various applications, crystallography being one of the most important ones. DECTRIS also provides solutions for customer developments in scientific and industrial X-ray detection.
Our proven, highly reliable products increase instrument uptime. Our scalable manufacturing system means shorter lead times and better technical support. DECTRIS is the hybrid photon counting detector company of choice for customers desiring premier performance, plus the confidence of working with a stable, trusted technology partner. For more information, visit www.dectris.com.
Investor Contact:
Miroslava Minkova
Bruker Head of Investor Relations
T: + (1) 663-3660 x1479
E: miroslava.minkova@bruker.com
Media Contacts:
Dr. Heiko Ress
Bruker AXS Director Marketing Communications
T: +(49) 721 50997-0
E: heiko.ress@bruker.com
Andreas Lechner
DECTRIS Head of Marketing and Communications
T: +(41) 56 500 31 28
E: andreas.lechner@dectris.com
The powerful combination of the D8 ADVANCE or the D8 DISCOVER with the EIGER2 R 500K significantly extends and speeds up the analysis capabilities for the community of XRD users.
Record changed: 2023-07-10 |
Advertisement
More documents for analytical instrument_other
- [1] Bruker Corporation. (10/4/23). "Press Release: Bruker Announces Majority Investment in MIRO Analytical AG, an Innovator in Compact, Highest-Precision QCL-Based Multi-Gas Analyzers (MGA)". Zürich....
- [2] Dynamic Biosensors GmbH. (9/1/22). "Press Release: 2bind and Dynamic Biosensors Sign Technology-Service Partnership". Munich & Regensburg....
- [3] Creoptix AG. (1/11/22). "Press Release: Malvern Panalytical Expands Pharmaceutical Drug Development Solutions through the Acquisition of Creoptix"....
- [4] Creoptix AG. (1/12/21). "Press Release: Domainex Invests in the Creoptix WAVEdelta to Strengthen Its Fragment-based Drug Discovery Platform. Strong Partnership Ahead". Wädenswil & Saffron Walden....
- [5] Creoptix AG. (11/25/20). "Press Release: Creoptix and oneservice Partner for WAVEsystem After-sales Support". Wädenswil (Zurich)....
- [6] Creoptix AG. (12/10/19). "Press Release: Creoptix Appoints Line Stigen Raquet as Chief Executive Officer". Wädenswil (Zurich)....
- [7] Bruker Corporation. (10/2/19). "Press Release: Bruker Announces Acquisition of Magnettech’s EPR Business". Freiberg....
- [8] Creoptix AG. (9/30/19). "Press Release: Creoptix Closes Successful Series C Financing Round to Support Further Growth". Wädenswil (Zurich)....
- [9] Bruker Corporation. (1/18/19). "Press Release: Bruker Launches the G6 Leonardo for Oxygen, Nitrogen and Hydrogen (ONH) Analysis by Inert Gas Fusion". Delhi....
- [10] Creoptix AG. (9/5/18). "Press Release: Creoptix Attracts Waters as Corporate Investor". Wädenswil (Zurich)....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement
» top